Competitive Bidding For High-End Devices? Ways & Means Reiterates “No”
This article was originally published in The Gray Sheet
A competitive bidding model that would give physicians the discretionary ability to prescribe a particular product brand is being evaluated by the House Ways & Means Committee
You may also be interested in...
Blood glucose monitors and test strips are product areas that may fall under a competitive bidding model in upcoming Medicare reform legislation, according to device stakeholders
The passage of a Medicare prescription drug benefit in the 108th Congress could lead to the expansion of competitive bidding processes beyond durable medical equipment to include non-DME devices, consultants and industry reps are forecasting
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.